Essential Tremor clinical trials at UCLA

1 in progress, 0 open to eligible people

SAGE-324 in Participants With Essential Tremor
Sorry, in progress, not accepting new patients
The primary purpose of this study is to evaluate the dose-response relationship of different doses of SAGE-324 on upper extremity tremor in participants with essential tremor (ET) in the monotherapy cohort.
Los Angeles, California and other locations

Last updated: March 1, 2024